atezolizumab
roche
['atezo']
#esmoimmuno22 detectable ctdna clearly prognostic with much shorter mdfs when controlling for pd-l1 status, with or without atezolizumab. but atezolizumab improved dfs in ctdna+ and ctdna- and to a very similar degree. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown, Host Official @IASLC Podcast #LCSM #HereWeGo #ITYSL